Merit Financial Group, LLC

SEC CIK: 0001621225
Latest filing: Jul 20, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Merit Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q2 2026 holdings

Shares (Q2 2026): 5,004
Value: $391.7K
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2025

Holdings of HALO by Merit Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	5,004	$391.7K	<0.1%	−608−10.8%	Reduced	Holders
Q1 2026	5,612	$362.7K	<0.1%	+5,612	New	Holders
Q4 2025	0	$0	0.0%	−3,289−100.0%	Sold out	Holders
Q3 2025	3,289	$241.2K	<0.1%	+3,289	New	Holders